Search results for: 'capture cells'

This edition of the Energy & Power Systems (EPS) TOE features information about the innovations in phase change materials for energy storage, tidal energy, agrivoltaics systems, floating PV, concentrated solar, LFP batteries, energy management systems, and tandem solar cells, among others.The Energy and Power Systems TOE provide insights on the lat...

This issue of High-Tech Materials Technology Opportunity Engine (TOE) profiles significant advancements in high-tech materials for various industrial applications. The featured innovations include Acoustic Metamaterial Absorption Technology, Tri-metal Automotive Emission Control Catalyst Technology, Interface and Materials Design in High-Efficiency...

20 Aug 2024  |  Global  |  Technology Research

Technological Advances in Regenerative Medicine

Disruptive Technology and a Competitive Landscape Drive Growth in Stem Cell Therapy Research

Infographics

×

Regenerative medicine has evolved significantly and today includes several commercialized stem cell therapies. Researchers have made notable technological developments in stem cell therapies to overcome challenges related to large-scale manufacturing and cell quality. Stem cell research is more focused on induced pluripotent stem cells than on mese...

This edition of the Energy & Power Systems (EPS) TOE features information about the innovations in direct drive technology for wind energy, N-type TOPCON photovoltaic module technology, proton exchange membrane fuel cells, solar thermal power generation, modular molten salt reactors, hard carbon-tin composite battery anodes, and alkaline battery sy...

19 Jan 2018  |  North America  |  Market Research

The Global Immuno-oncology Therapeutics Market—Adoptive T-cell Therapies, Forecast to 2022

The Next Generation of Cancer Therapies

Infographics

×

Key Issues Addressed

Immuno-oncology refers to drugs that are used to stimulate the human immune system to target the fight against cancer. The immune system is capable of recognizing and eliminating foreign substances, including tumor cells. Tumors have, however, been able to escape detection by the immune system. There are drugs that can empower the immune system cel...

Research Overview This Frost & Sullivan research service analyses the current trends, forecasts and the external factors influencing the global cell therapy market. It also studies top participants in the market, disruptive pipeline products, and the opportunities in combination therapy. In addition, it provides a detailed commercialization analys...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

This research service analyses the emerging stem cell therapeutics applications by geographic regions, encompassing Europe - The United Kingdom, Germany, Sweden, Belgium, Finland, France and Spain. The study covers various areas of interest such as regulatory policies within stem cell research, emerging companies, key business updates, analysis of ...

The revenue from 5G DIS and small cells in Asia-Pacific will increase from $3.26 billion in 2021 to $16.04 billion in 2026 at a CAGR of 37.6% from 2021 to 2026. From 2023, the market will accelerate as countries move into the recovery phase following the COVID-19 pandemic; mobile operators will be able to allocate more CAPEX to achieve greater grow...